Evidence map›Paper›PMID 36795682›Full record

ArticlePloS one2023

Alternate atxA and acpA dependent response of Bacillus anthracis to serum, HCO3- and CO2.

Itai Glinert, Elad Bar-David, Amir Ben-Shmuel, Assa Sittner, Reut Puni, Shira Laredo, David Kobiler, Shay Weiss, Haim Levy

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Persistence in time: the hunt forApplied and environmental microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Itai GlinertDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Elad Bar-DavidDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Amir Ben-ShmuelDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Assa SittnerDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Reut PuniDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Shira LaredoDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
David KobilerDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Shay WeissDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
Haim LevyDepartment of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.ORCID 0000-0002-1902-8535
Israel Institute for Biological Research · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacillus anthracis overcomes host immune responses by producing capsule and secreting toxins. Production of these virulence factors in response to entering the host environment was shown to be regulated by atxA, the major virulence regulator, known to be activated by HCO3- and CO2. While toxin production is regulated directly by atxA, capsule production is independently mediated by two regulators; acpA and acpB. In addition, it was demonstrated that acpA has at least two promotors, one of them shared with atxA. We used a genetic approach to study capsule and toxin production under different conditions. Unlike previous works utilizing NBY, CA or R-HCO3- medium under CO2 enriched conditions, we used a sDMEM-based medium. Thus, toxin and capsule production can be induced in ambient or CO2 enriched atmosphere. Using this system, we could differentiate between induction by 10% NRS, 10% CO2 or 0.75% HCO3-. In response to high CO2, capsule production is induced by acpA based response in an atxA-independent manner, with little to no toxin (protective antigen PA) production. atxA based response is activated in response to serum independently of CO2, inducing toxin and capsule production in an acpA or acpB dependent manner. HCO3- was also found to activate atxA based response, but in non-physiological concentrations. Our findings may help explain the first stages of inhalational infection, in which spores germinating in dendritic cells require protection (by encapsulation) without affecting cell migration to the draining lymph-node by toxin secretion.

Indexed as

Bacillus anthracisBacterial ToxinsAntigens, BacterialBacterial ProteinsCarbon DioxideGene Expression Regulation, BacterialAntigens, BacterialBacterial ProteinsBacterial ToxinsCarbon Dioxide

Identifiers

PMID36795682
PMCPMC9934324
OpenAlexW4321004311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.